Literature DB >> 11711329

Guidelines for the diagnosis and treatment of benign prostatic hyperplasia: a comparative, international overview.

C G Roehrborn1, G Bartsch, R Kirby, G Andriole, P Boyle, J de la Rosette, P Perrin, E Ramsey, J Nordling, G De Campos Freire, S Arap.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11711329     DOI： 10.1016/s0090-4295(01)01402-9

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


× No keyword cloud information.
  22 in total

1.  Update on the american urological association guidelines for the treatment of benign prostatic hyperplasia.

Authors:  Steven A Kaplan
Journal:  Rev Urol       Date:  2006

2.  Correlation between the total volume, transitional zone volume of the prostate, transitional prostate zone index and lower urinary tract symptoms (LUTS).

Authors:  Mario Franciosi; Walter José Koff; Ernani Luis Rhoden
Journal:  Int Urol Nephrol       Date:  2007-01-04       Impact factor: 2.370

3.  Comparison of TURP, TUVRP, and HoLEP.

Authors:  Narmada P Gupta; Ajay Anand
Journal:  Curr Urol Rep       Date:  2009-07       Impact factor: 3.092

4.  Efficacy of a vaporization-resection of the prostate median lobe enlargement and vaporization of the prostate lateral lobe for benign prostatic hyperplasia using a 120-W GreenLight high-performance system laser: the effect on storage symptoms.

Authors:  Kang Sup Kim; Sae Woong Choi; Woong Jin Bae; Su Jin Kim; Hyuk Jin Cho; Sung-Hoo Hong; Ji Youl Lee; Tae-Kon Hwang; Sae Woong Kim
Journal:  Lasers Med Sci       Date:  2015-04-02       Impact factor: 3.161

5.  Laser prostatectomy: holmium laser enucleation and photoselective laser vaporization of the prostate.

Authors:  Yakup Bostanci; Amir Kazzazi; Bob Djavan
Journal:  Rev Urol       Date:  2013

Review 6.  Management of bladder, prostatic and pelvic floor disorders.

Authors:  G Brisinda; G Maria; A R Bentivoglio; F Cadeddu; G Marniga; F Brandara; A Albanese
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

Review 7.  Doxazosin gastrointestinal therapeutic system: a review of its use in benign prostatic hyperplasia.

Authors:  David R Goldsmith; Greg L Plosker
Journal:  Drugs       Date:  2005       Impact factor: 9.546

8.  Development of a quality of life scale specific for patients with benign prostatic hyperplasia.

Authors:  Kamil Cam; Talha Muezzinoglu; Omer Aydemir; Recep Buyukalpelli; Gokhan Toktas; Hakan Gemalmaz
Journal:  Int Urol Nephrol       Date:  2013-02-19       Impact factor: 2.370

9.  Early Experience with Laparoscopic Retropubic Simple Prostatectomy in Patients with Voluminous Benign Prostatic Hyperplasia (BPH).

Authors:  Han Ki Yun; Joon Beom Kwon; Sung Ryong Cho; Jae Soo Kim
Journal:  Korean J Urol       Date:  2010-05-19

10.  Patterns in the diagnosis and management of benign prostatic hyperplasia in a country that does not have country-specific clinical practice guidelines.

Authors:  Jae-Seung Paick; Soo Woong Kim; Ja Hyeon Ku
Journal:  Yonsei Med J       Date:  2007-04-30       Impact factor: 2.759
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.